212 related articles for article (PubMed ID: 33705544)
1. Rimonabant potentiates the antifungal activity of amphotericin B by increasing cellular oxidative stress and cell membrane permeability.
Zhang M; Lu J; Duan X; Chen J; Jin X; Lin Z; Pang Y; Wang X; Lou H; Chang W
FEMS Yeast Res; 2021 Apr; 21(3):. PubMed ID: 33705544
[TBL] [Abstract][Full Text] [Related]
2. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
Rossi SA; de Oliveira HC; Agreda-Mellon D; Lucio J; Mendes-Giannini MJS; García-Cambero JP; Zaragoza O
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988099
[TBL] [Abstract][Full Text] [Related]
3. In vitro antifungal activities of amphotericin B in combination with acteoside, a phenylethanoid glycoside from Colebrookea oppositifolia.
Ali I; Sharma P; Suri KA; Satti NK; Dutt P; Afrin F; Khan IA
J Med Microbiol; 2011 Sep; 60(Pt 9):1326-1336. PubMed ID: 21474610
[TBL] [Abstract][Full Text] [Related]
4. Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
Barchiesi F; Schimizzi AM; Caselli F; Novelli A; Fallani S; Giannini D; Arzeni D; Di Cesare S; Di Francesco LF; Fortuna M; Giacometti A; Carle F; Mazzei T; Scalise G
Antimicrob Agents Chemother; 2000 Sep; 44(9):2435-41. PubMed ID: 10952592
[TBL] [Abstract][Full Text] [Related]
5. Lactoferrin Is Broadly Active against Yeasts and Highly Synergistic with Amphotericin B.
Fernandes KE; Weeks K; Carter DA
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094132
[TBL] [Abstract][Full Text] [Related]
6. The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug.
Mesa-Arango AC; Trevijano-Contador N; Román E; Sánchez-Fresneda R; Casas C; Herrero E; Argüelles JC; Pla J; Cuenca-Estrella M; Zaragoza O
Antimicrob Agents Chemother; 2014 Nov; 58(11):6627-38. PubMed ID: 25155595
[TBL] [Abstract][Full Text] [Related]
7. In vitro synergistic effects of fluoxetine and paroxetine in combination with amphotericin B against Cryptococcus neoformans.
Pereira TC; de Menezes RT; de Oliveira HC; de Oliveira LD; Scorzoni L
Pathog Dis; 2021 Feb; 79(2):. PubMed ID: 33417701
[TBL] [Abstract][Full Text] [Related]
8. Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans.
An M; Shen H; Cao Y; Zhang J; Cai Y; Wang R; Jiang Y
Int J Antimicrob Agents; 2009 Mar; 33(3):258-63. PubMed ID: 19095412
[TBL] [Abstract][Full Text] [Related]
9. Lysine enhances the effect of amphotericin B against Candida albicans in vitro.
Zhao L; Jiang J; Zhu Z; Liao Z; Yao X; Yang Y; Cao Y; Jiang Y
Acta Biochim Biophys Sin (Shanghai); 2016 Feb; 48(2):182-93. PubMed ID: 26711896
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid.
Al Jalali V; Sauermann R; Eberl S; Zeitlinger M
Infection; 2019 Aug; 47(4):565-570. PubMed ID: 30725316
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of the verapamil and amphotericin B against Cryptococcus neoformans.
Pereira TC; do Carmo PHF; de Menezes RT; de Oliveira HC; de Oliveira LD; Junqueira JC; Scorzoni L
Folia Microbiol (Praha); 2023 Dec; 68(6):999-1004. PubMed ID: 37950840
[TBL] [Abstract][Full Text] [Related]
12. Impact of iron chelators on growth and expression of iron-related genes of Cryptococcus species.
Chayakulkeeree M; Tangkoskul T; Waywa D; Tiengrim S; Pati N; Thamlikitkul V
J Mycol Med; 2020 Apr; 30(1):100905. PubMed ID: 31706700
[TBL] [Abstract][Full Text] [Related]
13. Synergistic Antifungal Activity of Isoquercitrin: Apoptosis and Membrane Permeabilization Related to Reactive Oxygen Species in Candida albicans.
Kim S; Woo ER; Lee DG
IUBMB Life; 2019 Feb; 71(2):283-292. PubMed ID: 30481395
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of pedalitin and amphotericin B against Cryptococcus neoformans by in vitro and in vivo evaluation.
Sangalli-Leite F; Scorzoni L; Alves de Paula E Silva AC; da Silva JF; de Oliveira HC; de Lacorte Singulani J; Gullo FP; Moraes da Silva R; Regasini LO; Siqueira da Silva DH; da Silva Bolzani V; Fusco-Almeida AM; Soares Mendes-Giannini MJ
Int J Antimicrob Agents; 2016 Nov; 48(5):504-511. PubMed ID: 27742203
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).
Medoff G; Kobayashi GS; Kwan CN; Schlessinger D; Venkov P
Proc Natl Acad Sci U S A; 1972 Jan; 69(1):196-9. PubMed ID: 4550505
[TBL] [Abstract][Full Text] [Related]
16. Mode of action and synergistic effect of valinomycin and cereulide with amphotericin B against Candida albicans and Cryptococcus albidus.
Makarasen A; Reukngam N; Khlaychan P; Chuysinuan P; Isobe M; Techasakul S
J Mycol Med; 2018 Mar; 28(1):112-121. PubMed ID: 29276078
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Antifungal Effect of Amphotericin B-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles and Ultrasound against Candida albicans Biofilms.
Yang M; Du K; Hou Y; Xie S; Dong Y; Li D; Du Y
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670414
[No Abstract] [Full Text] [Related]
18. Efficacy of liposomal amphotericin B against four species of Candida biofilms in an experimental mouse model of intravascular catheter infection.
Fujimoto K; Takemoto K
J Infect Chemother; 2018 Dec; 24(12):958-964. PubMed ID: 30209024
[TBL] [Abstract][Full Text] [Related]
19. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
Chen HH; Liushih RN; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
[TBL] [Abstract][Full Text] [Related]
20. Dectin-1-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy.
Ambati S; Ferarro AR; Kang SE; Lin J; Lin X; Momany M; Lewis ZA; Meagher RB
mSphere; 2019 Feb; 4(1):. PubMed ID: 30760610
[No Abstract] [Full Text] [Related]
[Next] [New Search]
